Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection

NCT05229991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: Lonafarnib
DRUG: Ritonavir

Sponsor

Soroka University Medical Center

Collaborators

[object Object]